CymitQuimica logo
MAPK

MAPK

Le MAPK sono una famiglia di chinasi proteiche coinvolte in una varietà di processi cellulari, tra cui crescita, proliferazione, differenziazione e risposte allo stress. La via di segnalazione MAPK è composta da diversi livelli, tra cui ERK, JNK e p38 MAPK, ciascuno con ruoli distinti nella funzione cellulare. La disregolazione della segnalazione MAPK è collegata al cancro, alle malattie infiammatorie e ai disturbi metabolici. Presso CymitQuimica, offriamo una vasta gamma di inibitori e attivatori delle MAPK per supportare la tua ricerca in biologia cellulare, trasduzione del segnale e meccanismi delle malattie.

Trovati 893 prodotti di "MAPK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • ERK1/2 inhibitor 3

    CAS:
    ERK1/2 inhibitor 3, a strong ERK1/2 blocker, may aid in cancer and inflammation research.
    Formula:C28H31ClFN5O6S
    Colore e forma:Solid
    Peso molecolare:620.09
  • MC 976

    CAS:
    MC 976 is a derivative of Vitamin D3.
    Formula:C27H42O3
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:414.63
  • Rac1 Inhibitor W56

    CAS:
    Peptide (45-60) blocks Rac1 binding with TrioN, GEF-H1, Tiam1 GEFs.
    Formula:C74H117N19O23S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:1671.93
  • Ras Inhibitory Peptide acetate


    <p>Ras Inhibitory Peptide acetate, involved in cancer-related Ras signaling.</p>
    Formula:C55H95N19O13
    Purezza:96.63%
    Colore e forma:Solid
    Peso molecolare:1230.46
  • Anti-inflammatory agent 31


    Andrographolide derivative 31 is an anti-inflammatory that blocks NF-κB, PI3K/Akt, and ERK1/2 MAPK, and restores GSH levels to protect the liver.
    Formula:C19H30O3
    Colore e forma:Solid
    Peso molecolare:306.44
  • Murrayafoline A

    CAS:
    Murrayafoline A is a useful organic compound for research related to life sciences. The catalog number is T124835 and the CAS number is 4532-33-6.
    Formula:C14H13NO
    Colore e forma:Solid
    Peso molecolare:211.264
  • SEPT9-IN-1


    SEPT9-IN-1 (compound 8b) is a SEPT9 inhibitor with an IC50 value of 94.83 μM. It exhibits cytotoxicity against human oral squamous carcinoma cells, with an IC50 of 21 µM.
    Formula:C26H30ClN3O3
    Colore e forma:Solid
    Peso molecolare:467.988
  • (R)-BI-2852

    CAS:
    (R)-5-hydroxy isoindolin-1-one is an RAS protein inhibitor with antiproliferative and antitumor properties.
    Formula:C31H28N6O2
    Purezza:97.78%
    Colore e forma:Soild
    Peso molecolare:516.59
  • KRAS inhibitor-38

    CAS:
    KRAS Inhibitor-38 (Example 18) is a potent inhibitor capable of effectively suppressing the activity of KRAS G12C, KRAS G12D, and KRAS G12V in vivo.
    Formula:C53H68ClF2N9O8S
    Colore e forma:Solid
    Peso molecolare:1064.68
  • RAS/RAS-RAF-IN-1

    CAS:
    RAS/RAS-RAF-IN-1: Potent RAS & RAS-RAF inhibitor, KD 5-15μM for CYPA, antitumor properties.
    Formula:C45H57N7O7
    Colore e forma:Solid
    Peso molecolare:807.993
  • JNK3 inhibitor-8


    JNK3 inhibitor-8: potent, selective, oral, BBB-penetrating, IC50: JNK3=21 nM, JNK2=2203 nM, JNK1>10,000 nM; potential in Alzheimer's research.
    Formula:C32H30FN7O3
    Colore e forma:Solid
    Peso molecolare:579.62
  • S6 Kinase Substrate Peptide 32


    S6 Kinase Substrate Peptide 32 is a peptide that measures the activity of kinases that phosphorylate ribosomal protein S6. It can also be used as a substrate.
    Formula:C149H270N56O49
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:3630.1
  • SS47

    CAS:
    SS47 is a PROTAC that degrades immunosuppressive HPK1 via proteasome; boosts BCMA CAR-T cell cancer therapy.
    Formula:C49H56N6O12S
    Colore e forma:Solid
    Peso molecolare:953.07
  • LC 2 Epimer

    CAS:
    <p>Negative control for LC 2.</p>
    Formula:C59H71ClFN11O7S
    Colore e forma:Solid
    Peso molecolare:1132.8
  • KRASG12C IN-14


    <p>KRASG12C IN-14 (compound 15), a potent inhibitor specifically designed for the KRAS G12C mutation, exhibits impressive efficacy in impeding CYPA-dependent KRAS-BRAF interaction and ERK phosphorylation in NCI-H358 cells, both with an IC 50 of 0.002 μM.</p>
    Formula:C51H65F4N9O9S2
    Colore e forma:Solid
    Peso molecolare:1088.24
  • (S)-BAY-293

    CAS:
    <p>(S)-BAY-293 is a potent pan-KRAS inhibitor for the study of primary non-small lung and pancreatic cancers.</p>
    Formula:C25H28N4O2S
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:448.58
  • KRAS G12C inhibitor 18

    CAS:
    KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities.
    Formula:C25H20ClFN4O3S
    Colore e forma:Solid
    Peso molecolare:510.97
  • KRas G12R inhibitor 1


    KRas G12R inhibitor 1 targets mutant cysteines in K-Ras, binds irreversibly, and is used in cancer research.
    Formula:C39H38ClF7N6O9
    Colore e forma:Solid
    Peso molecolare:903.2
  • HPK1-IN-8

    CAS:
    <p>HPK1-IN-8 is an allosteric, inactive, conformation-selective triazolopyrimidine ketone HPK1 inhibitor.</p>
    Formula:C19H17FN6O2S
    Purezza:99.68%
    Colore e forma:Solid
    Peso molecolare:412.44
  • MAP4K4-IN-6


    MAP4K4-IN-6 (Compound 15f) is a MAP4K4 inhibitor with an IC50 of 80 nM. It reduces the phosphorylation of c-Jun and exhibits neuroprotective effects. Additionally, MAP4K4-IN-6 enhances the vitality of motor neurons and can be utilized in the study of amyotrophic lateral sclerosis (ALS).
    Colore e forma:Odour Solid